ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.40, sa.2, ss.75-80, 2012 (SCI-Expanded)
Background: Erythropoietin (EPO) is originally defined as a haematopoietic growth factor, but also has anti-inflammatory effects through cytokine modulation. This anti-inflammatory and cytokine modulating effect has not been investigated for the treatment of asthma. We aimed to determine the beneficial effects of erythropoietin on lung histology of murine model of chronic asthma.